Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 320.36M | 226.60M | 248.11M | 232.56M | 74.98M |
| Total Receivables | 2.92M | 1.45M | 2.47M | 1.91M | 300.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.70M | 4.56M | 3.97M | 2.34M | 2.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 327.98M | 232.61M | 254.55M | 236.81M | 77.47M |
|
|
|||||
| Total Current Assets | 327.98M | 232.61M | 254.55M | 236.81M | 77.47M |
| Net Property, Plant & Equipment | 2.54M | 2.58M | 2.73M | 2.87M | 3.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 312.00K | 312.00K | 312.00K | 312.00K | 312.00K |
| Total Assets | 330.83M | 235.51M | 257.59M | 240.00M | 80.78M |
|
|
|||||
| Total Accounts Payable | 1.18M | 1.13M | 1.17M | 1.68M | 743.00K |
| Total Accrued Expenses | 5.35M | 4.20M | 10.14M | 8.79M | 5.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 612.00K | 590.00K | 569.00K | 548.00K | 533.00K |
| Total Finance Division Other Current Liabilities | 16.30M | 29.08M | 36.90M | 42.36M | 40.92M |
| Total Other Current Liabilities | 16.30M | 29.08M | 36.90M | 42.36M | 40.92M |
| Total Current Liabilities | 23.45M | 35.00M | 48.78M | 53.38M | 47.29M |
|
|
|||||
| Total Current Liabilities | 23.45M | 35.00M | 48.78M | 53.38M | 47.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.74M | 1.90M | 2.06M | 2.21M | 2.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.72M | 13.04M |
| Total Liabilities | 25.18M | 36.90M | 50.84M | 57.30M | 62.68M |
|
|
|||||
| Common Stock & APIC | 1.15B | 1.04B | 1.04B | 1.04B | 863.32M |
| Retained Earnings | -844.98M | -841.13M | -832.05M | -854.14M | -844.94M |
| Treasury Stock & Other | -623.00K | -368.00K | -41.00K | -90.00K | -279.00K |
| Total Common Equity | 305.65M | 198.61M | 206.75M | 182.70M | 18.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 305.65M | 198.61M | 206.75M | 182.70M | 18.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 305.65M | 198.61M | 206.75M | 182.70M | 18.10M |
|
|
|||||